| The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors EG Mietlicki-Baase, PI Ortinski, LE Rupprecht, DR Olivos, AL Alhadeff, ... American Journal of Physiology-Endocrinology and Metabolism 305 (11), E1367 …, 2013 | 171 | 2013 |
| Astrocytes regulate GLP-1 receptor-mediated effects on energy balance DJ Reiner, EG Mietlicki-Baase, LE McGrath, DJ Zimmer, KK Bence, ... Journal of Neuroscience 36 (12), 3531-3540, 2016 | 114 | 2016 |
| Glucagon-like peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine HD Schmidt, EG Mietlicki-Baase, KY Ige, JJ Maurer, DJ Reiner, ... Neuropsychopharmacology 41 (7), 1917-1928, 2016 | 111 | 2016 |
| Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling EG Mietlicki-Baase, PI Ortinski, DJ Reiner, CG Sinon, JE McCutcheon, ... Journal of Neuroscience 34 (20), 6985-6992, 2014 | 102 | 2014 |
| Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose MR Hayes, EG Mietlicki-Baase, SE Kanoski, BC De Jonghe Annual review of nutrition 34, 237-260, 2014 | 93 | 2014 |
| Amylin modulates the mesolimbic dopamine system to control energy balance EG Mietlicki-Baase, DJ Reiner, JJ Cone, DR Olivos, LE McGrath, ... Neuropsychopharmacology 40 (2), 372-385, 2015 | 89 | 2015 |
| Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake EG Mietlicki-Baase, LE Rupprecht, DR Olivos, DJ Zimmer, MD Alter, ... Neuropsychopharmacology 38 (9), 1685-1697, 2013 | 89 | 2013 |
| Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats NS Hernandez, KY Ige, EG Mietlicki-Baase, GC Molina-Castro, CA Turner, ... Neuropsychopharmacology 43 (10), 2000-2008, 2018 | 88 | 2018 |
| Thioamide substitution selectively modulates proteolysis and receptor activity of therapeutic peptide hormones X Chen, EG Mietlicki-Baase, TM Barrett, LE McGrath, K Koch-Laskowski, ... Journal of the American Chemical Society 139 (46), 16688-16695, 2017 | 80 | 2017 |
| Amylin activates distributed CNS nuclei to control energy balance EG Mietlicki-Baase, MR Hayes Physiology & behavior 136, 39-46, 2014 | 60 | 2014 |
| Amylin-mediated control of glycemia, energy balance, and cognition EG Mietlicki-Baase Physiology & behavior 162, 130-140, 2016 | 54 | 2016 |
| Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior EG Mietlicki-Baase, LE McGrath, K Koch-Laskowski, J Krawczyk, ... Neuropharmacology 123, 67-79, 2017 | 53 | 2017 |
| Glucagon-like peptide-1 receptor signaling in the lateral dorsal tegmental nucleus regulates energy balance DJ Reiner, RM Leon, LE McGrath, K Koch-Laskowski, JD Hahn, ... Neuropsychopharmacology 43 (3), 627-637, 2018 | 49 | 2018 |
| Amylin acts in the lateral dorsal tegmental nucleus to regulate energy balance through gamma-aminobutyric acid signaling DJ Reiner, EG Mietlicki-Baase, DR Olivos, LE McGrath, DJ Zimmer, ... Biological psychiatry 82 (11), 828-838, 2017 | 49 | 2017 |
| Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake EG Mietlicki-Baase, DR Olivos, BA Jeffrey, MR Hayes American Journal of Physiology-Endocrinology and Metabolism 308 (12), E1116 …, 2015 | 46 | 2015 |
| Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt LE Rupprecht, EG Mietlicki-Baase, DJ Zimmer, LE McGrath, DR Olivos, ... American Journal of Physiology-Endocrinology and Metabolism 305 (6), E751-E759, 2013 | 42 | 2013 |
| Binge‐type eating disrupts dopaminergic and GABAergic signaling in the prefrontal cortex and ventral tegmental area RLW Corwin, FHE Wojnicki, DJ Zimmer, RK Babbs, LE McGrath, ... Obesity 24 (10), 2118-2125, 2016 | 37 | 2016 |
| Glucagon-like peptide 1 in the brain: where is it coming from, where is it going? D Daniels, EG Mietlicki-Baase Diabetes 68 (1), 15, 2019 | 35 | 2019 |
| A vitamin B12 conjugate of exendin‐4 improves glucose tolerance without associated nausea or hypophagia in rodents EG Mietlicki‐Baase, CG Liberini, JL Workinger, RL Bonaccorso, T Borner, ... Diabetes, Obesity and Metabolism 20 (5), 1223-1234, 2018 | 30 | 2018 |
| Amylin in Alzheimer's disease: Pathological peptide or potential treatment? EG Mietlicki-Baase Neuropharmacology 136, 287-297, 2018 | 27 | 2018 |
Matthew R HayesAlbert J. Stunkard Professor in Psychiatry, University of PennsylvaniaAdresse e-mail validée de mail.med.upenn.edu
